Free Trial

Salarius Pharmaceuticals (SLRX) SEC Filings & 10K Form

Salarius Pharmaceuticals logo
$0.75 0.00 (-0.17%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$0.76 +0.01 (+0.67%)
As of 07/25/2025 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Salarius Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/21/2025
7:39 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
7:33 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
11:00 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
7:38 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2025
8:26 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEF 14A
05/27/2025
8:30 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEFA14A
05/15/2025
4:18 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form PRE 14A
03/28/2025
3:30 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2025
3:30 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
5:56 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
5:00 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B5
01/21/2025
7:01 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/17/2025
4:17 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:36 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 424B3
01/13/2025
7:09 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2024
11:15 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form EFFECT
12/27/2024
3:35 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
12/23/2024
11:22 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
5:12 AM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/01/2024
4:05 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEFA14A
11/01/2024
4:04 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form DEF 14A
09/27/2024
3:01 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
4:10 PM
Salarius Pharmaceuticals, Inc. (Filer)
Salarius Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLRX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners